← Back to Search

Genetic Testing

Fetal Genome Profiling for Fetal Growth Restriction

N/A

Waitlist Available

Led By Kangpu Xu, PhD, DVM

Research Sponsored by Weill Medical College of Cornell University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be between 18 and 65 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 16 weeks post pregnancy

Awards & highlights

Study Summary

This trial will test whether cells from the early pregnancy can be used for prenatal testing, which could improve early pregnancy management.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 16 weeks post pregnancy

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~16 weeks post pregnancy

This trial's timeline: 3 weeks for screening, Varies for treatment, and 16 weeks post pregnancy for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Occurrence of chromosomal anomalies as detected via fetal genome analysis of trophoblast cells

Secondary outcome measures

Occurrence of chromosomal anomalies detected via trophoblast cell analysis as compared to occurrence of chromosomal anomalies detected via preimplantation genetic testing (PGT), chorionic villi sampling (CVS), amniocentesis, or cytogenetic results.

Trial Design

1Treatment groups

Experimental Treatment

Group I: Fetal Genome ProfilingExperimental Treatment1 Intervention

Trophoblast cells will be collected from the cervix approximately 5-6 weeks once pregnancy is achieved.

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Weill Medical College of Cornell UniversityLead Sponsor

1,054 Previous Clinical Trials

1,316,308 Total Patients Enrolled

Kangpu Xu, PhD, DVMPrincipal InvestigatorWeill Medical College of Cornell University

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is this experiment enrolling geriatric patients?

"According to the study's requirements, any potential participants must be of legal consent (18+) and no older than 45 years old."

Answered by AI

Are any spots still available for potential participants in this research project?

"The data hosted on clinicaltrials.gov displays that this medical trial is actively recruiting participants, with the initial post made in July 2nd 2020 and most recent edits occurring on July 27th 2022."

Answered by AI

Am I eligible to contribute to this experiment?

"To be accepted in this experiment, participants must present with fetal growth retardation and have to fit within the 18-45 age bracket. 70 individuals are eligible for inclusion."

Answered by AI

Could you tell me the upper limit of participants in this research?

"Affirmative - according to clinicaltrials.gov, this research is currently recruiting patients after being published on July 2nd 2020 and updated on July 27th 2022. The trial requires 70 volunteers from a single facility."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Fetal Genome Profiling Via Trophoblast Cells

2020. "Fetal Genome Profiling Via Trophoblast Cells". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03832634.